SCHEMBL2064358

SCHEMBL2064358

Fc1ccc(N2CCCCC2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.71
▸ RAB9A P51151 4/20 0.71
▸ ALDH1A1 P00352 7/20 0.68
▸ MAPT P10636 6/20 0.68
▸ TP53 P04637 4/20 0.68
▸ KDM4E B2RXH2 4/20 0.68
▸ MAPK1 P28482 3/20 0.68
▸ NPSR1 Q6W5P4 2/20 0.68
▸ HPGD P15428 1/20 0.68
▸ TSHR P16473 1/20 0.68
▸ CASP1 P29466 1/20 0.68
▸ CASP7 P55210 1/20 0.68
▸ HTT P42858 3/20 0.61
▸ LMNA P02545 2/20 0.61
▸ TDP1 Q9NUW8 2/20 0.61
▸ GFER P55789 1/20 0.61
▸ ALOX15 P16050 2/20 0.59
▸ SMN1; SMN2 Q16637 2/20 0.59
▸ POLB P06746 2/20 0.58
▸ MEN1 O00255 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12799147 1.00 NPC1 (0.71) NPC1RAB9AALDH1A1MAPTTP53
Hydrochloric Acid SCHEMBL2159983 0.98 NPC1 (0.69) NPC1RAB9AALDH1A1MAPTTP53
SCHEMBL1821338 0.97 ALDH1A1 (0.70) NPC1RAB9AALDH1A1MAPTTP53
Hydrochloric Acid SCHEMBL22031645 0.95 MAPT (0.68) NPC1RAB9AALDH1A1MAPTTP53
SCHEMBL5760520 0.93 NPC1 (0.65) NPC1RAB9AALDH1A1MAPTTP53
SCHEMBL16404482 0.92 MAPT (0.64) NPC1RAB9AALDH1A1MAPTTP53
SCHEMBL8577561 0.88 NPC1 (0.59) NPC1RAB9AALDH1A1MAPTTP53
SCHEMBL10373626 0.87 MAPT (0.77) NPC1RAB9AALDH1A1MAPTTP53
SCHEMBL6887590 0.87 ALDH1A1 (0.71) NPC1RAB9AALDH1A1MAPTTP53
SCHEMBL22495739 0.86 MAPT (0.69) NPC1RAB9AALDH1A1MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107428730-A New 1,3,5 triazine radical PI3K inhibitor as antitumor and anticancer agent and preparation method thereof 科学与工业研究会 2017-12-01 — — CN claimed
CN-106452100-A Three-level photovoltaic grid-connected inverter based on DSP control and working method of three-level photovoltaic grid-connected inverter 江苏建筑职业技术学院 2017-02-22 — — CN claimed
CN-102239146-A Novel compounds as calcium channel blockers ABBOTT LAB 2011-11-09 — — CN claimed
CN-1440390-A Substituted diamine derivatives as motilin antagonists ORTHO MCNEIL PHARM INC (US) 2003-09-03 — — CN claimed
EP-1294695-A2 SUBSTITUTED DIAMIDE DERIVATIVES USEFUL AS MOTILIN ANTAGONISTS Ortho-McNeil Pharmaceutical, Inc. (US) 2003-03-26 — — EP claimed
WO-2001085694-A2 SUBSTITUTED DIAMIDE DERIVATIVES USEFUL AS MOTILIN ANTAGONISTS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2001-11-15 — — WO claimed
EP-0846676-B1 Process for the preparation of aromatic amines from aryl chlorides AXIVA GMBH (DE) 2001-02-07 — — EP claimed
CN-117756747-A Preparation method of N-phenyl nitrogen-containing polycyclic quaternary ammonium salt compound 济宁医学院 2024-03-26 — — CN disclosed
EP-4126840-A1 ARYL PIPERIDINES AS MONOACYLGLYCEROL LIPASE MODULATORS Janssen Pharmaceutica NV (BE) 2023-02-08 — — EP disclosed
EP-3459948-B1 FLUORINE-CONTAINING TRIAZOLOPYRIDINE, AND MANUFACTURING METHOD, PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF SHANGHAI INST MATERIA MEDICA CAS (CN) 2021-11-17 — — EP disclosed
EP-3371196-B1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF PLATELET AGGREGATION UNIV MONTREAL (CA) 2021-10-27 — — EP disclosed
CN-107383002-B Fluorine-containing triazole pyridine compounds, and preparation method, pharmaceutical composition and application thereof 中国科学院上海药物研究所 2021-07-13 — — CN disclosed
US-10800776-B2 Fluorine-containing triazolopyridine, and manufacturing method, pharmaceutical composition, and application thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2020-10-13 — — US disclosed
CN-1261366-A Azothiazine compounds and pyrrolethiazepine compounds having 5-hydroxytryptamine-2-receptor antagonistic and alpha-1-blocking effects SUNTORY LTD (JP) 2000-07-26 — — CN disclosed
CN-1260798-A Has 5-hydroxytryptamine-2 receptor antagonistic effect and alpha1Azothiazine and pyrrolethiazepine compounds with blocking action SUNTORY LTD (JP) 2000-07-19 — — CN disclosed
CN-1219173-A Pyrroloazepine compounds SUNTORY LTD (JP) 1999-06-09 — — CN disclosed
US-5831128-A Synthesis of aromatic amines from chloroamatics HOECHST AKTIENGESELLSCHAFT (DE) 1998-11-03 — — US disclosed
EP-0846676-A1 Process for the preparation of aromatic amines from aryl chlorides HOECHST AKTIENGESELLSCHAFT (DE) 1998-06-10 — — EP disclosed
US-5554383-A ADMINISTERING SELECTIVE SEROTONIN REUPTAKE INHIBITOR TRUSTEES OF TUFTS COLLEGE (US) 1996-09-10 — — US disclosed
CN-1119859-A benzothiazine derivatives SUNTORY LTD (JP) 1996-04-03 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10800776-B2 Fluorine-containing triazolopyridine, and manufacturing method, pharmaceutical composition, and application thereof GRM2, GRM1, GRIK2 NPC1 2063/4885RAB9A 1656/4885ALDH1A1 3621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback